Sort Results:

List of News


  • Date: 24 January 2014
  • The true test for new Alzheimers drugs is in human clinical trials. Numerous treatments for Alzheimers disease have been shown to be safe and to have some positive effect when tested in animal models of Alzheimers disease. However, many of these...

  • Creation of a new Dementia Consortium - The Dementia Consortium

  • Date: 11 March 2014
  • Announcing the creation of a collaborative drug discovery initiative to help support target validation studies for novel targets in neurodegenerative disease. OUR GOAL: Identifying dementia research with drug development potential and working...

  • CTFs 2014 Drug Discovery Initiative

  • Date: 26 March 2014
  • The Children's Tumor Foundation Drug Discovery Initiative Awards program supports early stage testing of candidate drug therapies for the treatment of neurofibromatosis (NF): F1, NF2 and schwannomatosis. Established in 2006, DDI Awards has to ...

  • Seeding Drug Discovery Funding Available from Wellcome Trust

  • Date: 18 April 2014
  • Funding to facilitate early-stage small-molecule drug discovery. The awards help applicants with a potential drug target or new chemistry embark on a programme of compound discovery and/or take later stage projects towards clinical trials.

    The aim of...

  • Translation Fund Available from Wellcome Trust

  • Date: 19 April 2014
  • Translating innovative and ambitious, applied R&D projects with an unmet healthcare need. The aim of Translation Awards is to develop innovative and ground breaking new technologies in the biomedical area.

    Projects must have already demonstrated...

  • Cheryl Arrowsmith has been appointed to the ADDC Board of Directors

  • Date: 01 April 2014
  • The Academic Drug Discovery Consortium is proud to announce the appointment of Cheryl Arrowsmith. She is a Senior Scientist at Princess Margaret Cancer Centre and Professor in the Department of Medical Biophysics at the University of Toronto, where...